Codagenix Completes Dosing in Phase 1 Trial of Universal Influenza Vaccine

/PRNewswire/ -- Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology...

Related Keywords

Australia ,J Robert Coleman , ,Prnewswire Codagenix Inc ,Chief Executive Officer ,Codagenix ,Nc ,